Another mechanism involves the degradation of the antigen–antibody complex or the rapid elimination of myeloma cells expressing high levels of CD38, as demonstrated by the fact that MM CD38 levels were only reduced in the presence of complement or effector cells. The gene discussed is CD38; the disease is Miyoshi myopathy.